Skip to content

MCderm

Active Private limited companyfounded 2022active for 4 yearsRue de la Croix Hustin 43, 1470 GenappeKBO/BCE: BE 0791.971.346

Lifetime

3 annual accounts with figures on one time axis
peak of €110,286 in 2023
€29,462▼ 62.8%
lowest -€39,945 in 2025
-€39,945▼ €95,292
peak of €133,282 in 2024
€93,337▼ 30.0%
€61,858▲ 25×
Board1 name since 2022
1 director
Documentsfilings and deeds
20-05-202672 days before the deadline
2025micro format
Gross margin from €79,298 to €29,462Loss of €39,945Equity from €133,282 to €93,337Debts from €2,428 to €61,858Cash from €55,245 to €89,493

Key points

from the 2025 annual accounts

Result

-€39,945 -€39,945
€55,3002024-€39,9002025

From profit to loss in 2025, after a profit of €55,348 in 2024.

Liquidity

2.64 was 55.33 in 2024

Short-term debts rose from €2,428 to €58,589.

Position in the sector

-€39,945

Lower net result than 95% of companies in human health. The sector median is €59,520, over 21,372 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,235 companies had the same profile as MCderm has now. Each dot stands for 9 companies, two years later.

87.5%
were still trading
8.9%
stopped another way
3.3%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,235 companies, not a prediction for MCderm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
  • 100 sharesdeed of 10-10-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0791971346
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director and managing director · published on 10-10-2022 · Gazette deed
First establishment Rue de la Croix Hustin 43, Genappe
All 9 events

Comparable companies

same main activity, similar in size and age
Company
MCderm Genappe €155,195 €29,462 60.1% -
BENIUGA ANAPATH CONSULTING Pont-à-Celles €153,053 €33,336 95.1% -
REGENIX Ixelles €129,705 €33,442 47.9% -
2 QURATIO Sint-Truiden €182,730 €31,215 21.7% 0
COSMODERMIC Woluwe-Saint-Lambert €123,510 €34,999 70.4% -
Dr Morello Caroline Ophtalmologie Uccle €184,074 €35,485 90.1% -
Dr. Beeckmans Nele - Fysische Geneeskunde, Revalidatie en Sportgeneeskunde Hoegaarden €141,132 €30,008 99.5% -

These companies have the same main activity as MCderm: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €124,000 and €184,000, founded between 2021 and 2022.

Official details

Source: KBO
Status
Active since 06-10-2022Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.336.668.9291470 Genappe, since 06-10-2022
Financial year end
31 December
Peppol
Reachable since 08-01-2026
Company details

Annual accounts 2025

≈ €91,000estimated
€155,195▲ 14.4%
Filing
Filed on 20-05-2026, 72 days before the end of the filing period
Financials

Insights on MCderm

MCderm files the micro format. That format states no turnover. The gross margin fell from €110,286 in 2023 to €29,462 in 2025.

In October 2022, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MCderm

What is the company number of MCderm?
The company number of MCderm is 0791.971.346. The VAT number is the same number with BE in front: BE 0791.971.346.
Where is MCderm based?
The registered office is at Rue de la Croix Hustin 43, 1470 Genappe.Company details
What does MCderm do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MCderm?
MCderm is a private limited company (BV).
When was MCderm founded?
MCderm was founded on 06-10-2022.
Is MCderm still active?
Yes, MCderm is an active enterprise in the KBO register.
What is the turnover of MCderm?
The turnover in financial year 2025 is about €91,000. This figure is estimated from the gross margin of €29,462 and 47 comparable companies (NACE 86). It probably lies between €65,000 and €130,000.Financials
Is MCderm profitable?
In financial year 2025, MCderm made a loss of €39,945.
Where can I find the annual accounts of MCderm?
MCderm filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MCderm due?
MCderm must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.